SEQUENTIAL OESTROGEN/PROGESTERONE ANTAGONIST COMBINATION FOR HORMONE REPLACEMENT THERAPY

摘要

This invention relates to a pharmaceutical agent thatcontains in combination individual dosage units of an estrogenand individual dosage units of a competitive progesteroneantagonist for separate, sequential administration thereof, whichcan be used for hormone replacement therapy, as well as packagingthat contains this pharmaceutical agent.